---
title: "Cellyan Biotechnology Co., Ltd (HKPD.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/HKPD.US.md"
symbol: "HKPD.US"
name: "Cellyan Biotechnology Co., Ltd"
industry: "Air Freight and Logistics"
datetime: "2026-05-20T06:06:09.065Z"
locales:
  - [en](https://longbridge.com/en/quote/HKPD.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/HKPD.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/HKPD.US.md)
---

# Cellyan Biotechnology Co., Ltd (HKPD.US)

## Company Overview

Cellyan Biotechnology Co., Ltd, an investment holding company, engages in the over the counter (OTC) pharmaceutical business in Hong Kong and Mainland China. The company provides OTC pharmaceutical cross-border procurement and distribution and e-commerce supply chain services. It also offers custom clearance, drugs enlisting, warehouse, and other logistics services. The company serves e-commerce platform logistics partners, merchants, and pharmaceutical distributors.

| Item | Detail |
|------|--------|
| Industry | Air Freight and Logistics |
| Exchange | US Market |
| Website | [www.9zt.hk](https://www.9zt.hk) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: C
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-20T04:30:15.000Z

**Overall: C (0.58)**

**Industry**: Air Freight and Logistics

| Metric | Value |
|--------|-------|
| Industry Ranking | 18 / 28 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: C

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -21.23% |  |
| Net Profit YoY | -136.76% |  |
| P/B Ratio | 2.44 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 12548992.52 |  |
| Revenue | 16359769.00 |  |

#### Multi Score Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -13.37% | D |
| Profit Margin | -4.29% | D |
| Gross Margin | 13.04% | D |
| Revenue YoY | -21.23% | E |
| Net Profit YoY | -136.76% | E |
| Total Assets YoY | -5.20% | D |
| Net Assets YoY | -3.90% | D |
| Cash Flow Margin | 60.97% | C |
| OCF YoY | -21.23% | E |
| Turnover | 1.65 | A |
| Gearing Ratio | 46.61% | C |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Cellyan Biotechnology Co., Ltd",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "-21.23%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "-136.76%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "2.44",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "12548992.52",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "16359769.00",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "-13.37%",
          "rating": "D"
        },
        {
          "name": "Profit Margin",
          "value": "-4.29%",
          "rating": "D"
        },
        {
          "name": "Gross Margin",
          "value": "13.04%",
          "rating": "D"
        },
        {
          "name": "Revenue YoY",
          "value": "-21.23%",
          "rating": "E"
        },
        {
          "name": "Net Profit YoY",
          "value": "-136.76%",
          "rating": "E"
        },
        {
          "name": "Total Assets YoY",
          "value": "-5.20%",
          "rating": "D"
        },
        {
          "name": "Net Assets YoY",
          "value": "-3.90%",
          "rating": "D"
        },
        {
          "name": "Cash Flow Margin",
          "value": "60.97%",
          "rating": "C"
        },
        {
          "name": "OCF YoY",
          "value": "-21.23%",
          "rating": "E"
        },
        {
          "name": "Turnover",
          "value": "1.65",
          "rating": "A"
        },
        {
          "name": "Gearing Ratio",
          "value": "46.61%",
          "rating": "C"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -17.88 | 26/28 | 8.58 | 7.61 | 6.40 |
| PB | 2.44 | 14/28 | 2.97 | 2.54 | 1.76 |
| PS (TTM) | 0.77 | 14/28 | 0.80 | 0.64 | 0.43 |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Deutsche Post AG (DPSTF.US) | B | C | A | D | B | B |
| 02 | Deutsche Post AG (DHLGY.US) | B | C | A | D | B | B |
| 03 | DSV A/S (DSDVY.US) | C | B | A | D | A | B |
| 04 | Expeditors (EXPD.US) | B | C | A | C | C | B |
| 05 | ZTO Express (ZTO.US) | B | B | C | B | B | B |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/HKPD.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/HKPD.US/norm.md)
- [Related News](https://longbridge.com/en/quote/HKPD.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/HKPD.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**